Thomas Strack
Direttore Tecnico/Scientifico/R&S presso VTV THERAPEUTICS INC.
Profilo
Thomas Strack is currently the Chief Medical Officer at vTv Therapeutics, Inc. He previously worked as the Vice President of Clinical Affairs at Progenics Pharmaceuticals, Inc., Head of Metabolic Clinical Development at Takeda Global Research & Development Center, Inc., Head of Research & Development at Asubio Pharmaceutical, Inc., and Chief Medical Officer at Faeth Therapeutics, Inc. He holds a doctorate degree from The Johannes Gutenberg University of Mainz.
Posizioni attive di Thomas Strack
| Società | Posizione | Inizio |
|---|---|---|
| VTV THERAPEUTICS INC. | Direttore Tecnico/Scientifico/R&S | 02/11/2023 |
Precedenti posizioni note di Thomas Strack
| Società | Posizione | Fine |
|---|---|---|
Faeth Therapeutics, Inc.
 Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Direttore Tecnico/Scientifico/R&S | - |
| Takeda Global Research & Development Center, Inc. | Corporate Officer/Principal | - |
Asubio Pharmaceutical, Inc.
 Asubio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Asubio Pharmaceutical, Inc. was into pharmaceuticals sector. The company was headquartered in Paramus, NY. | Direttore Tecnico/Scientifico/R&S | - |
| PROGENICS PHARMACEUTICALS, INC. | Corporate Officer/Principal | - |
Formazione di Thomas Strack
| The Johannes Gutenberg University of Mainz | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| VTV THERAPEUTICS INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Progenics Pharmaceuticals, Inc.
 Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Progenics Pharmaceuticals, Inc. engages in the development of medicines and other products for targeting and treating cancer. Its pipeline includes therapeutic agents, imaging agents for prostate cancer, and imaging analysis technology. The company was founded by Paul J. Maddon on December 1, 1986 and is headquartered in New York, NY. | Health Technology |
| Takeda Global Research & Development Center, Inc. | |
Asubio Pharmaceutical, Inc.
Asubio Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Asubio Pharmaceutical, Inc. was into pharmaceuticals sector. The company was headquartered in Paramus, NY. | Health Technology |
Faeth Therapeutics, Inc.
Faeth Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Faeth Therapeutics, Inc. is a clinical-stage biotechnology company based in TX. The American company focuses on developing precision therapies for metabolic oncology using a machine-learning platform and a metabolic regimen involving the patient's diet. Faeth's lead program combines FTH-001 and FTH-003 with an insulin suppressing regimen to slow tumor growth by shutting down the PI3K/MTOR pathway. The company's scientific founders include Drs. Lew Cantley, Sid Mukherjee, and Karen Vousden. Anand Parikh has been the CEO since incorporation. | Health Technology |
- Borsa valori
- Insiders
- Thomas Strack
